|Bid||0.00 x 900|
|Ask||140.00 x 1000|
|Day's Range||132.19 - 135.00|
|52 Week Range||118.62 - 148.32|
|PE Ratio (TTM)||267.34|
|Forward Dividend & Yield||3.60 (2.68%)|
|1y Target Est||N/A|
The cover story in this weekend's Barron's examines how blockchain technology is beginning to show promise. Other featured articles include income picks from top advisors and five standout dividend picks. ...
In 2012, Baxter International (BAX) adopted a $2 billion share buyback program. In November 2016 and February 2018, the company increased the program by $1.5 billion each.
As we discussed earlier, Allergan (AGN) has restructured its business over the last few years, and it now reports its revenues in three business segments.
U.S. equities soared on Thursday, reversing a two-week malaise, after Walmart (NYSE:WMT) reported solid results and headlines that China’s Vice Commerce Minister would visit the United States for trade talks in late August. Analysts are looking for earnings of $1.15-per-share on revenues of $10.9 billion.
Bayer's (BAYRY) Monsanto subsidiary faces $289 million fine in Roundup lawsuit. Merck/Eisai's drug Lenvima gets FDA approval to treat the most common form of liver cancer.
Allergan (AGN) is a leading specialty pharmaceutical company focused on developing, manufacturing, and commercializing pharmaceutical and biological products.
Glaxo (GSK) and Johnson and Johnson report positive top line results from a late-stage study of their injectable two-drug regimen for the treatment of HIV.
Houston Business Journal hosted its “Future of Health Care Panel” on Aug. 10 at the Junior League of Houston to chat with industry leaders about notable trends in health care they see and experience every day.
WASHINGTON/NEW YORK, Aug 16 (Reuters) - The Trump administration on Thursday proposed that U.S. drugmakers cut production quotas of the six most abused opioids by 10 percent next year to fight a nationwide addiction crisis. In a statement, the U.S. Justice Department and Drug Enforcement Administration (DEA) said the proposed cut would be in keeping with President Donald Trump's effort to cut opioid prescription fills by one-third within three years. Trump on Thursday also pressed U.S. Attorney General Jeff Sessions to sue drug manufacturers over the opioid crisis.
Bausch Health Companies’ (BHC) wholly-owned subsidiary Ortho Dermatologics generated revenue of $142.0 million in the second quarter compared to $162 million in the second quarter of 2017, reflecting a ~12% YoY (year-over-year) fall.
Johnson & Johnson (JNJ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Amarin and Geron are both racing toward major binary events that could pay off for early shareholders in a big way.
How Is Vertex Pharmaceuticals Positioned in August? On February 12, the FDA approved Vertex Pharmaceuticals’ (VRTX) Symdeko, which is the company’s third cystic fibrosis drug in the US market. Symdeko continues to witness a strong launch in the US market, and demand has risen across the entire range of eligible patients.
Bausch + Lomb, an international subsidiary of Bausch Health Companies (BHC), generated revenue of $1.21 billion in the second quarter compared to $1.22 billion in the second quarter of 2017, reflecting a ~1% YoY (year-over-year) fall. However, Bausch + Lomb witnessed ~4% YoY organic growth in the second quarter.
People who have a rare genetic mutation called essential fructosuria lack the primary enzyme needed to metabolize fructose, a natural sugar found in honey, fruits and vegetables. No ill consequences have been linked to the defect, save for an aversion to sweets, and it appears to have a significant benefit: Those who have it seem to be at little risk of obesity, type 2 diabetes or serious liver ailments. “When I started contacting people who were taking care of these patients, there was literally no one — I couldn’t find anyone — who was fat or had type 2 diabetes,” said Richard Johnson, a pioneering metabolic-disease scientist at the University of Denver.
Erika Hayes James became the first African-American woman appointed dean of a top-25 business school when she was tapped for the role at the John H. Harland Dean of Goizueta Business School in 2014.
One popular form of dividend investing involves a group of stocks called dividend aristocrats. Standards of what makes up a dividend aristocrat vary. Of the thousands of stocks that trade on American exchanges, only 53 stocks currently hold dividend aristocrat status.
In this daily bar chart of JNJ, below, we can see that JNJ has been testing the declining 200-day moving average line. The daily On-Balance-Volume (OBV) line has been going up since early June and it is close to making a new high above the April peak. A rising OBV line is a sign that buyers of a stock are being more aggressive.
Shire's (SHPG) Japanese partner Shionogi & Co., Ltd submits a new drug application for Intuniv in Japan for the treatment of attention deficit hyperactivity disorder (ADHD) in adults.
Aug.15 -- People who have a rare genetic mutation called essential fructosuria lack the primary enzyme needed to metabolize fructose, a natural sugar found in honey, fruits and vegetables. No ill consequences have been linked to the defect, save for an aversion to sweets, and it appears to have a significant benefit: Those who have it seem to be at little risk of obesity, type 2 diabetes or serious liver ailments. Bloomberg's Timothy Annett has more on "What'd You Miss?"